TNFα contributes for attenuating both Y397 FAK and Y416Src phosphorylations in osteoblasts (2014)
Source: Oral Diseases. Unidade: FOB
Subjects: LIPOPOLISSACARÍDEOS, DOENÇAS PERIODONTAIS, OSTEOBLASTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVAGIS, A. D. M. et al. TNFα contributes for attenuating both Y397 FAK and Y416Src phosphorylations in osteoblasts. Oral Diseases, v. No 2014, n. 8, p. 780-786, 2014Tradução . . Disponível em: https://doi.org/10.1111/odi.12202. Acesso em: 10 nov. 2024.APA
Cavagis, A. D. M., Takamori, E. R., Granjeiro, J. M., Oliveira, R. C. de, Ferreira, C. V., Peppelenbosch, M. P., & Zambuzzi, W. F. (2014). TNFα contributes for attenuating both Y397 FAK and Y416Src phosphorylations in osteoblasts. Oral Diseases, No 2014( 8), 780-786. doi:10.1111/odi.12202NLM
Cavagis ADM, Takamori ER, Granjeiro JM, Oliveira RC de, Ferreira CV, Peppelenbosch MP, Zambuzzi WF. TNFα contributes for attenuating both Y397 FAK and Y416Src phosphorylations in osteoblasts [Internet]. Oral Diseases. 2014 ; No 2014( 8): 780-786.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/odi.12202Vancouver
Cavagis ADM, Takamori ER, Granjeiro JM, Oliveira RC de, Ferreira CV, Peppelenbosch MP, Zambuzzi WF. TNFα contributes for attenuating both Y397 FAK and Y416Src phosphorylations in osteoblasts [Internet]. Oral Diseases. 2014 ; No 2014( 8): 780-786.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/odi.12202
